文献速递肿瘤 PET/CT放射性药物与辐射防护

光声成像无标记可视化早期癌症肝微转移并指导术中手术

Label-Free Visualization of Early Cancer Hepatic Micrometastasis and Intraoperative Image-Guided Surgery by Photoacoustic Imaging.
PubMed 文献 · J Nucl Med · 2019-12-05

该研究在小鼠黑色素瘤肝转移模型中评估光声成像(PAI)检测早期肝微转移及术中引导切除的性能,并与超声、9.4-T MRI、PET/CT和生物发光成像比较。PAI可检测体内深度达7 mm、大小约400 μm的转移灶,第8天和第14天肿瘤-肝脏信号比显著高于PET/CT(P<0.001),并成功实现便携式PAI引导的术中切除。

要点

  • PAI可检测体内深度达7 mm、大小约400 μm的肝微转移灶。
  • 第8天和第14天PAI肿瘤-肝脏信号比显著高于PET/CT(P<0.001)。
  • 便携式PAI系统成功引导黑色素瘤肝转移的术中切除。

核心结论

  • 光声成像可快速、有效地辅助无创检测微转移并引导术中切除。

研究设计与样本

  • 研究经厦门大学动物伦理委员会批准,建立B16黑色素瘤肝转移小鼠模型(n=10)以研究体内微转移发展。
  • 小鼠依次接受可扩展PAI仪器、超声、9.4-T高分辨率MRI、PET/CT和生物发光成像检查,PAI采用680-850 nm波长并以线性最小二乘法进行光谱解混。
  • 不同模态间信噪比差异采用双尾配对t检验分析,诊断结果以组织学检查评估,并检查了肝癌症患者切除肝样本以识别肿瘤边界。

主要发现

  • PAI在体内可检测小至约400 μm、深度达7 mm的转移灶,小于超声和MRI可检测的大小。
  • PAI第8天肿瘤-肝脏比为4.2 ± 0.2(n=6),第14天为9.2 ± 0.4(n=5),显著高于PET/CT的1.8 ± 0.1(n=5)和4.5 ± 0.2(n=5),两项P均<0.001。
  • 功能性PAI显示肿瘤生长过程中动态氧饱和度变化。
  • 体外检测限约为219 cells/μL。
  • 使用便携式PAI系统成功在体内完成术中PAI引导手术。

临床怎么用

  • PAI可作为无标记、快速的补充成像手段,用于早期肝微转移检测。
  • 便携式PAI系统可辅助术中引导转移灶切除。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The detection of cancer micrometastasis for early diagnosis and treatment poses a great challenge for conventional imaging techniques. The aim of our study was to evaluate the performance of photoacoustic imaging (PAI) in detecting hepatic micrometastases from melanoma at a very early stage and in aiding tumor resection by intraoperative guidance. Methods: In vivo studies were performed by following protocols approved by the Ethical Committee for Animal Research at Xiamen University. First, a mouse model of B16 melanoma metastatic to the liver (n = 10) was established to study the development of micrometastases in vivo. Next, the mice were imaged by a scalable PAI instrument, ultrasound, 9.4-T high-resolution MRI, PET/CT, and bioluminescence imaging. PAI scans acquired with optical wavelengths of 680-850 nm were kept spectrally unmixed by using a linear least-squares method to differentiate various components. Differences in signal-to-background ratios among different modalities were determined with the 2-tailed paired t test. The diagnostic results were assessed with histologic examination. Excised liver samples from patients diagnosed with hepatic cancer were also examined to identify the tumor boundaries. Surgical removal of metastatic melanoma was precisely guided in vivo by the portable PAI system. Results: PAI was able to detect metastases as small as approximately 400 μm at a depth of up to 7 mm in vivo-a size that is smaller than can be detected with ultrasound and MRI. The tumor-to-liver ratio for PAI at 8 d (4.2 ± 0.2, n = 6) and 14 d (9.2 ± 0.4, n = 5) was significantly higher than for PET/CT (1.8 ± 0.1, n = 5, and 4.5 ± 0.2, n = 5, respectively; P < 0.001 for both). Functional PAI revealed dynamic oxygen saturation changes during tumor growth. The limit of detection was approximately 219 cells/μL in vitro. We successfully performed intraoperative PAI-guided surgery in vivo using the portable PAI system. Conclusion: Our findings offer a rapid and effective complementary clinical imaging application to noninvasively detect micrometastases and guide intraoperative resection.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Yu Q, Huang S, Wu Z, et al. Label-Free Visualization of Early Cancer Hepatic Micrometastasis and Intraoperative Image-Guided Surgery by Photoacoustic Imaging. J Nucl Med. 2019. PMID: 31806769. doi:10.2967/jnumed.119.233155

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。